The machinery that activates programmed cell death (PCD) appears to be present in many, if not all cells that do not normally die. It is therefore essential to repress PCD in cells destined to survive. Many of the molecular events that repress PCD in living cells are not well defined and we are performing studies to identify and characterize novel mechanisms that keep PCD inactive in surviving cells. Genetic studies have shown that the
egl-1 ,
ced-3 , and
ced-4 genes are necessary for nearly all PCD in C. elegans . We recently reported that the ICD-1 apoptotic suppressor inhibits CED-4-dependent, CED-3-independent PCD (Bloss, et al., Nature 424, 2003), revealing that the pro-apoptotic actions of CED-3 and CED-4 are separable. Derepression of the cell death program in essential cells, as seen in mutants defective for the
ced-9 apoptotic suppressor, leads to lethality that is suppressible by mutations in the pro-apoptotic genes
ced-3 and
ced-4 . In an effort to identify additional PCD suppressors, we have performed an RNAi screen for lethal mutants that are suppressed by a
ced-4(-) mutation. From a screen of ~900 genes that exhibit RNAi-induced embryonic or larval lethality, we have identified >40 candidate genes that show suppression of lethality, ranging from mild to >100-fold suppression in a
ced-4 mutant. Progress on characterization of these newly identified CED-4-dependent lethal genes will be reported.